Sponsored Content
Parenteral drug development is complex, costly, and subject to many levels of risk during the clinical phases. Only a few drug products ever make it to phase III, through approval, and on into commercial manufacturing. Given the numerous hurdles that exist, realizing the drug development process efficiently during all phases has become ever more important. And, having the right partner on board to support the project is critical in preparing a valuable drug package that can be used for either further product development and commercialization, or for a successful out-licensing deal.
Parenteral drug development is complex, costly, and subject to many levels of risk during the clinical phases. Only a few drug products ever make it to phase III, through approval, and on into commercial manufacturing. Given the numerous hurdles that exist, realizing the drug development process efficiently during all phases has become ever more important. And, having the right partner on board to support the project is critical in preparing a valuable drug package that can be used for either further product development and commercialization, or for a successful out-licensing deal.
The podcast will showcase Vetter´s service portfolio as a company in general, and its offering in the development service area in detail. In addition, this podcast will focus on the companies` capabilities in its Chicago development service site, including its customer base. An informative case study highlighting the critical expertise needed in today´s drug development environment will be presented.